jupiterneurosciences.com (JUNS): Net earnings per share growth forecast for next year
Due to the macro-resilience of neuropharmaceuticals, demand for drugs remains stable, complemented by the partnership of Jupiter Neurosciences Inc (JUNS) with academic centers fighting Alzheimer's disease. The company's forward EPS dynamics model demonstrates yield trends, where the 0.00 mark reflects the latest data. Development success ensures the loyalty of a compact staff of leading neurologists, eliminating the risk of losing valuable personnel.
Metric breakdowns and analytics for Jupiter Neurosciences Inc (JUNS)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
Total Debt to Capital Jupiter Neurosciences Inc|JUNS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Jupiter Neurosciences, Inc.|JUNS - Company Aggregate Debts|Debt to Book Capitalization Ratio Jupiter Neurosciences|JUNS - Company Long-Term Loans and Borrowings|Company Short-Term Debt Jupiter Neurosciences|Quick Liquidity jupiterneurosciences.com
- earnings and market ratios statistics:
JUNS - Net Financial Result|Projected Future Earnings Jupiter Neurosciences Inc|JUNS - Price to Earnings Ratio|Forward P/E Multiple jupiterneurosciences.com|JUNS - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Jupiter Neurosciences|JUNS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Jupiter Neurosciences|JUNS - Earnings per share for the last 12 months|Quarterly EPS earnings growth jupiterneurosciences.com|JUNS - Net earnings per share growth this year|Earnings growth forecast for next year Jupiter Neurosciences Inc
- sales and revenue indicators:
Basic company analysis:JUNS, Jupiter Neurosciences Inc
The development of neuroprotectors on the Jotrol platform determines the commercialization potential of Jupiter Neurosciences Inc (JUNS) technologies for crossing the blood-brain barrier. This trend is reflected in the profit growth forecast, which measures the expected change in earnings per share (EPS) based on consolidated expert estimates. Investors should interpret the current real-time assessment of the company's EPS growth for the coming year as an indicator of market optimism or a signal for a trend reversal.
Competitor analysis for Jupiter Neurosciences Inc
Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros) - Earnings growth forecast for next year|NGNE - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year AC Immune Corp (ACIU)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (neumoratx.com)|SCLX - Expected earnings per share growth for next year|tevogen.com - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Alpha Cognition Inc. (ACOG)|CGTX: Earnings growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SAVA|Expected earnings per share growth for next year Assertio (ASRT)|Expected earnings per share growth for next year COYA (Coya)|Net earnings per share growth forecast for next year VTGN (VistaGen Therapeutics Inc)|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|Earnings growth forecast for next year Acumen Pharma ABOS|CervoMed, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year ATHE (alteritytherapeutics.com)|CLNN (Clene Nanomedicine) - Expected earnings per share growth for next year|Expected net earnings per share growth next year PepGen Corp (PEPG)|RLMD (relmada.com) - Earnings growth forecast for next year|Earnings growth forecast for next year Annovis Bio Corporation|Earnings growth forecast for next year GRCE|AIFF: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year
